Registro:

Referencias:

• Delvinge, A., Rozenberg, S., Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): A review (2002) Human Reproduction Update, 8 (6), pp. 559-577. , DOI 10.1093/humupd/8.6.559
• Aboulghar, M.A., Mansour, R.T., Ovarian hyperstimulation syndrome: Classifications and critical analysis of preventive measures (2003) Human Reproduction Update, 9 (3), pp. 275-289. , DOI 10.1093/humupd/dmg018
• Rizk, B., Aboulghar, M., Modern management of ovarian hyperstimulation syndrome (1991) Hum. Reprod., 6, pp. 1082-1087
• Fiedler, K., Ezcurra, D., Predicting and preventing ovarian hyperstimulation syndrome (OHSS): The need for individualized not standardized treatment (2012) Reprod. Biol. Endocrinol., 10, p. 32
• Golan, A., Ron-El, R., Herman, A., Soffer, Y., Weinraub, Z., Caspi, E., Ovarian hyperstimulation syndrome: An updata review (1989) Obstetrical and Gynecological Survey, 44 (6), pp. 430-440
• Gomez, R., Soares, S.R., Busso, C., Garcia-Velasco, J.A., Simon, C., Pellicer, A., Physiology and pathology of ovarian hyperstimulation syndrome (2010) Semin. Reprod. Med., 28, pp. 448-457
• Nastri, C.O., Ferriani, R.A., Rocha, I.A., Martins, W.P., Ovarian hyperstimulation syndrome: Pathophysiology and prevention (2010) J. Assist. Reprod. Genet., 27, pp. 121-128
• Senger, D.R., Galli, S.J., Dvorak, A.M., Perruzzi, C.A., Harvey, V.S., Dvorak, H.F., Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid (1983) Science, 219, pp. 983-985
• Shalaby, F., Rossant, J., Yamaguchi, T.P., Gertsenstein, M., Wu, X.F., Breitman, M.L., Schuh, A.C., Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice (1995) Nature, 376, pp. 62-66
• Verheul, H.M.W., Hoekman, K., Jorna, A.S., Smit, E.F., Pinedo, H.M., Targeting vascular endothelial growth factor blockade: Ascites and pleural effusion formation (2000) Oncologist, 5 (SUPPL. 1), pp. 45-50
• Abramovich, D., Rodriguez, C.A., Hernandez, F., Tesone, M., Parborell, F., Spatiotemporal analysis of the protein expression of angiogenic factors and their related receptors during folliculogenesis in rats with and without hormonal treatment (2009) Reproduction, 137, pp. 309-320
• Endo, T., Kitajima, Y., Nishikawa, A., Manase, K., Shibuya, M., Kudo, R., Cyclic changes in expression of mRNA of vascular endothelial growth factor, its receptors Flt-1 and KDR/Flk-1, and Ets-1 in human corpora lutea (2001) Fertility and Sterility, 76 (4), pp. 762-768. , DOI 10.1016/S0015-0282(01)02012-X, PII S001502820102012X
• Phillips, H.S., Hains, J., Leung, D.W., Ferrara, N., Vascular endothelial growth factor is expressed in rat corpus luteum (1990) Endocrinology, 127 (2), pp. 965-967
• Hazzard, T.M., Nayak, N.R., Brenner, R.M., Stouffer, R.L., Dynamic expression of receptors for vascular endothelial growth factor (VEGFR1, VEGFR2) and angiopioetins (TIE-2) in the primate corpus luteum (CL) during the menstrual cycle (2000) Biol. Reprod., 62, p. 271
• Yamamoto, S., Konishi, I., Mandai, M., Kuroda, H., Komatsu, T., Nanbu, K., Sakahara, H., Mori, T., Expression of vascular endothelial growth factor (VEGF) in epithelial ovarian neoplasms: Correlation with clinicopathology and patient survival, and analysis of serum VEGF levels (1997) British Journal of Cancer, 76 (9), pp. 1221-1227
• Yan, Z., Weich, H.A., Bernart, W., Breckwoldt, M., Neulen, J., Vascular endothelial growth factor (VEGF) messenger ribonucleic acid (mRNA) expression in luteinized human granulosa cells in vitro (1993) Journal of Clinical Endocrinology and Metabolism, 77 (6), pp. 1723-1725. , DOI 10.1210/jc.77.6.1723
• Neulen, J., Yan, Z., Raczek, S., Weindel, K., Keck, C., Weich, H.A., Marme, D., Breckwoldt, M., Human chorionic gonadotropin-dependent expression of vascular endothelial growth factor/vascular permeability factor in human granulosa cells: Importance in ovarian hyperstimulation syndrome (1995) J. Clin. Endocrinol. Metab., 80, pp. 1967-1971
• Albert, C., Garrido, N., Mercader, A., Rao, C.V., Remohi, J., Simon, C., Pellicer, A., The role of endothelial cells in the pathogenesis of ovarian hyperstimulation syndrome (2002) Molecular Human Reproduction, 8 (5), pp. 409-418
• Groten, T., Fraser, H.M., Duncan, W.C., Konrad, R., Kreienberg, R., Wulff, C., Cell junctional proteins in the human corpus luteum: Changes during the normal cycle and after HCG treatment (2006) Human Reproduction, 21 (12), pp. 3096-3102. , DOI 10.1093/humrep/del286
• Rodewald, M., Herr, D., Fraser, H.M., Hack, G., Kreienberg, R., Wulff, C., Regulation of tight junction proteins occludin and claudin 5 in the primate ovary during the ovulatory cycle and after inhibition of vascular endothelial growth factor (2007) Molecular Human Reproduction, 13 (11), pp. 781-789. , DOI 10.1093/molehr/gam066
• Dejana, E., Endothelial cell-cell junctions: Happy together (2004) Nature Reviews Molecular Cell Biology, 5 (4), pp. 261-270. , DOI 10.1038/nrm1357
• Schneeberger, E.E., Lynch, R.D., The tight junction: A multifunctional complex (2004) Am. J. Physiol. Cell Physiol., 286, pp. 1213-C1228
• Rodewald, M., Herr, D., Duncan, W.C., Fraser, H.M., Hack, G., Konrad, R., Gagsteiger, F., Wulff, C., Molecular mechanisms of ovarian hyperstimulation syndrome: Paracrine reduction of endothelial claudin 5 by hCG in vitro is associated with increased endothelial permeability (2009) Hum. Reprod., 24, pp. 1191-1199
• Lampugnani, M.G., Endothelial cell-to-cell junctions: Adhesion and signaling in physiology and pathology (2012) Cold Spring Harb. Perspect. Med., 2. , 10.1101/cshperspect.a006528
• Bazzoni, G., Dejana, E., Endothelial cell-to-cell junctions: Molecular organization and role in vascular homeostasis (2004) Physiological Reviews, 84 (3), pp. 869-901. , DOI 10.1152/physrev.00035.2003
• Dejana, E., Tournier-Lasserve, E., Weinstein, B.M., The control of vascular integrity by endothelial cell junctions: Molecular basis and pathological implications (2009) Dev. Cell, 16, pp. 209-221
• Pedram, A., Razandi, M., Levin, E.R., Deciphering vascular endothelial cell growth factor/vascular permeability factor signaling to vascular permeability inhibition by atrial natriuretic peptide (2002) Journal of Biological Chemistry, 277 (46), pp. 44385-44398. , DOI 10.1074/jbc.M202391200
• Krasnow, J.S., Zeleznik, A.J., Berga, S.L., Yeo, K.-T., Guzick, D.S., Vascular permeability factor and vascular endothelial growth factor in ovarian hyperstimulation syndrome: A preliminary report (1996) Fertility and Sterility, 65 (3), pp. 552-555
• Geva, E., Jaffe, R.B., Role of vascular endothelial growth factor in ovarian physiology and pathology (2000) Fertil. Steril., 74, pp. 429-438
• Lee, A., Burry, K.A., Christenson, L.K., Patton, P.E., Stouffer, R.L., Vascular endothelial growth factor levels in serum and follicular fluid of patients undergoing in vitro fertilization (1997) Fertility and Sterility, 68 (2), pp. 305-311. , DOI 10.1016/S0015-0282(97)81520-8, PII S0015028297002057
• Abramovich, D., Parborell, F., Tesone, M., Effect of a vascular endothelial growth factor (VEGF) inhibitory treatment on the folliculogenesis and ovarian apoptosis in gonadotropin-treated prepubertal rats (2006) Biology of Reproduction, 75 (3), pp. 434-441. , DOI 10.1095/biolreprod.106.051052
• Parborell, F., Abramovich, D., Tesone, M., Intrabursal administration of the antiangiopoietin 1 antibody produces a delay in rat follicular development associated with an increase in ovarian apoptosis mediated by changes in the expression of BCL2 related genes (2008) Biology of Reproduction, 78 (3), pp. 506-513. , http://www.biolreprod.org/cgi/reprint/78/3/506?ck=nck, DOI 10.1095/biolreprod.107.063610
• Kitajima, Y., Endo, T., Manase, K., Nishikawa, A., Shibuya, M., Kudo, R., Gonadotropin-releasing hormone agonist administration reduced vascular endothelial growth factor (VEGF), VEGF receptors, and vascular permeability of the ovaries of hyperstimulated rats (2004) Fertility and Sterility, 81 (SUPPL. 1), pp. 842-849. , DOI 10.1016/j.fertnstert.2003.11.012, PII S0015028203030607
• Kitajima, Y., Endo, T., Nagasawa, K., Manase, K., Honnma, H., Baba, T., Hayashi, T., Saito, T., Hyperstimulation and a gonadotropin-releasing hormone agonist modulate ovarian vascular permeability by altering expression of the tight junction protein claudin-5 (2006) Endocrinology, 147 (2), pp. 694-699. , http://endo.endojournals.org/cgi/reprint/147/2/694, DOI 10.1210/en.2005-0700
• Irusta, G., Parborell, F., Peluffo, M., Manna, P.R., Gonzalez-Calvar, S.I., Calandra, R., Stocco, D.M., Tesone, M., Steroidogenic acute regulatory protein in ovarian follicles of gonadotropin-stimulated rats is regulated by a gonadotropin-releasing hormone agonist (2003) Biology of Reproduction, 68 (5), pp. 1577-1583. , DOI 10.1095/biolreprod.102.009944
• Irusta, G., Parborell, F., Tesone, M., Inhibition of cytochrome P-450C17 enzyme by a GnRH agonist in ovarian follicles from gonadotropin-stimulated rats (2007) Am. J. Physiol. Endocrinol. Metab., 292, pp. 1456-E1464
• Woodruff, T.K., D'Agostino, J., Schwartz, N.B., Mayo, K.E., Dynamic changes in inhibin messenger RNAs in rat ovarian follicles during the reproductive cycle (1988) Science, 239, pp. 1296-1299
• Andreu, C., Parborell, F., Vanzulli, S., Chemes, H., Tesone, M., Regulation of follicular luteinization by a gonadotropin-releasing hormone agonist: Relationship between steroidogenesis and apoptosis (1998) Molecular Reproduction and Development, 51 (3), pp. 287-294. , DOI 10.1002/(SICI)1098-2795(1998 11)51:3<287::AI D-MRD8>3.0.CO;2-L
• Sadrkhanloo, R., Hofeditz, C., Erickson, G.F., Evidence for widespread atresia in the hypophysectomized estrogen-treated rat (1987) Endocrinology, 120 (1), pp. 146-155
• Augustin, H.G., Braun, K., Telemenakis, I., Modlich, U., Kuhn, W., Ovarian angiogenesis. Phenotypic characterization of endothelial cells in a physiological model of blood vessel growth and regression (1995) Am. J. Pathol., 147, pp. 339-351
• Redmer, D.A., Doraiswamy, V., Bortnem, B.J., Fisher, K., Jablonka-Shariff, A., Grazul-Bilska, A.T., Reynolds, L.P., Evidence for a role of capillary pericytes in vascular growth of the developing ovine corpus luteum (2001) Biology of Reproduction, 65 (3), pp. 879-889
• Cherry, J.A., Hou, X., Rueda, B.R., Davis, J.S., Townson, D.H., Microvascular endothelial cells of the bovine corpus luteum: A comparative examination of the estrous cycle and pregnancy (2008) Journal of Reproduction and Development, 54 (3), pp. 183-191. , http://www.jstage.jst.go.jp/article/jrd/54/3/183/_pdf, DOI 10.1262/jrd.19182
• Abramovich, D., Irusta, G., Parborell, F., Tesone, M., Intrabursal injection of vascular endothelial growth factor trap in eCG-treated prepubertal rats inhibits proliferation and increases apoptosis of follicular cells involving the PI3K/AKT signaling pathway (2010) Fertil. Steril., 93, pp. 1369-1377
• Levin, E.R., Rosen, G.F., Cassidenti, D.L., Yee, B., Meldrum, D., Wisot, A., Pedram, A., Role of vascular endothelial cell growth factor in ovarian hyperstimulation syndrome (1998) Journal of Clinical Investigation, 102 (11), pp. 1978-1985
• Gomez, R., Simon, C., Remohi, J., Pellicer, A., Vascular endothelial growth factor receptor-2 activation induces vascular permeability in hyperstimulated rats, and this effect is prevented by receptor blockade (2002) Endocrinology, 143 (11), pp. 4339-4348. , DOI 10.1210/en.2002-220204
• Ozcakir, H.T., Giray, S.G., Ozbilgin, M.K., Uyar, Y., Lacin, S., Caglar, H., Immunohistochemical detection of transforming growth factor-α, epidermal growth factor, and vascular endothelial growth factor expression in hyperstimulated rat ovary (2005) Acta Obstetricia et Gynecologica Scandinavica, 84 (9), pp. 887-893. , DOI 10.1111/j.0001-6349.2005.00586.x
• Scotti, L., Irusta, G., Abramovich, D., Tesone, M., Parborell, F., Administration of a gonadotropin-releasing hormone agonist affects corpus luteum vascular stability and development and induces luteal apoptosis in a rat model of ovarian hyperstimulation syndrome (2011) Mol. Cell Endocrinol., 335, pp. 116-125
• Gharbiya, L., Iannetti, F., De Vico, U., Mungo, M.L., Marenco, M., Visual and anatomical outcomes of intravitreal aflibercept for treatment-resistant neovascular age-related macular degeneration (2014) Biomed. Res. Int., 2014. , 273754
• Chang, A.A., Li, H., Broadhead, G.K., Hong, T., Schlub, T.E., Wijeyakumar, W., Zhu, M., Intravitreal aflibercept for treatment-resistant neovascular age-related macular degeneration (2014) Ophthalmology, 121, pp. 188-192
• Navot, D., Bergh, P.A., Laufer, N., Ovarian hyperstimulation syndrome in novel reproductive technologies: Prevention and treatment (1992) Fertil. Steril., 58, pp. 249-261
• Stocco, C., Telleria, C., Gibori, G., The molecular control of corpus luteum formation, function, and regression (2007) Endocrine Reviews, 28 (1), pp. 117-149. , http://edrv.endojournals.org/cgi/reprint/28/1/117, DOI 10.1210/er.2006-0022
• Rizk, B., Aboulghar, M., Smitz, J., Ron-El, R., The role of vascular endothelial growth factor and interleukins in the pathogenesis of severe ovarian hyperstimulation syndrome (1997) Human Reproduction Update, 3 (3), pp. 255-266. , DOI 10.1093/humupd/3.3.255
• Reynolds, L.P., Grazul-Bilska, A.T., Redmer, D.A., Angiogenesis in the corpus luteum (2000) Endocrine, 12 (1), pp. 1-9
• Fraser, H.M., Wilson, H., Wulff, C., Rudge, J.S., Wiegand, S.J., Administration of vascular endothelial growth factor Trap during the 'post-angiogenic' period of the luteal causes rapid functional luteolysis and selective endothelial cell death in the marmoset (2006) Reproduction, 132 (4), pp. 589-600. , DOI 10.1530/rep.1.01064
• Klagsbrun, M., D'Amore, P.A., Vascular endothelial growth factor and its receptors (1996) Cytokine and Growth Factor Reviews, 7 (3), pp. 259-270. , DOI 10.1016/S1359-6101(96)00027-5
• Wulff, C., Wilson, H., Wiegand, S.J., Rudge, J.S., Fraser, H.M., Prevention of thecal angiogenesis, antral follicular growth, and ovulation in the primate by treatment with vascular endothelial growth factor trap R1R2 (2002) Endocrinology, 143 (7), pp. 2797-2807. , DOI 10.1210/en.143.7.2797
• Sato, S., Kanno, N., Abe, M., Ito Shitara, K., Shibuya, M., Properties of two VEGF receptors, Flt-1 and KDR, in signal transduction (2000) Ann. N.Y. Acad. Sci., 902, pp. 201-205
• Shen, B.-Q., Lee, D.Y., Gerber, H.-P., Keyt, B.A., Ferrara, N., Zioncheck, T.F., Homologous up-regulation of KDR/Flk-1 receptor expression by vascular endothelial growth factor in vitro (1998) Journal of Biological Chemistry, 273 (45), pp. 29979-29985. , DOI 10.1074/jbc.273.45.29979
• Fujio, Y., Walsh, K., Akt mediates cytoprotection of endothelial cells by vascular endothelial growth factor in an anchorage-dependent manner (1999) J. Biol. Chem., 274, pp. 16349-16354
• Banerjee, S., Mehta, S., Haque, I., Sengupta, K., Dhar, K., Kambhampati, S., Van Veldhuizen, P.J., Banerjee, S.K., VEGF-A165 induces human aortic smooth muscle cell migration by activating neuropilin-1-VEGFR1-PI3K axis (2008) Biochemistry, 47 (11), pp. 3345-3351. , DOI 10.1021/bi8000352
• Walz, A., Keck, C., Weber, H., Kissel, C., Pietrowski, D., Effects of luteinizing hormone and human chorionic gonadotropin on corpus luteum cells in a spheroid cell culture system (2005) Molecular Reproduction and Development, 72 (1), pp. 98-104. , DOI 10.1002/mrd.20325
• Morita, K., Sasaki, H., Furuse, M., Tsukita, S., Endothelial claudin: Claudin-5/TMVCF constitutes tight junction strands in endothelial cells (1999) Journal of Cell Biology, 147 (1), pp. 185-194. , DOI 10.1083/jcb.147.1.185
• Lippoldt, A., Liebner, S., Andbjer, B., Kalbacher, H., Wolburg, H., Haller, H., Fuxe, K., Organization of choroid plexus epithelial and endothelial cell tight junctions and regulation of claudin-1, -2 and -5 expression by protein kinase C (2000) NeuroReport, 11 (7), pp. 1427-1431
• Hirase, T., Staddon, J.M., Saitou, M., Ando-Akatsuka, Y., Itoh, M., Furuse, M., Fujimoto, K., Rubin, L.L., Occludin as a possible determinant of tight junction permeability in endothelial cells (1997) Journal of Cell Science, 110 (14), pp. 1603-1613
• Antonetti, D.A., Barber, A.J., Khin, S., Lieth, E., Tarbell, J.M., Gardner, T.W., Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content. Vascular endothelial growth factor decreases occludin in retinal endothelial cells (1998) Diabetes, 47 (12), pp. 1953-1959
• Herr, D., Fraser, H.M., Konrad, R., Holzheu, I., Kreienberg, R., Wulff, C., Human chorionic gonadotropin controls luteal vascular permeability via vascular endothelial growth factor by down-regulation of a cascade of adhesion proteins (2013) Fertil. Steril., 99, pp. 1749-1758

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------